Patient organization input share in drug health technology assessments
STO-REC-STAT2PDYD6T3 Research
21%
Global · as of 5 Oct 2023
Patient organization input share in drug health technology assessments worldwide stood at 21% as of 5 October 2023 (IQVIA).
- Publisher
- IQVIA
- Authority tier
- T3 Research
- Locator
- Patient organizations now provide input into 21% of all drug health technology assessments (HTAs) globally and up to 52% in some therapy areas in EU and Commonwealth countries.
- Retrieved
- 16 Sep 2026
- Status
- Verified
What the source says
Patient organizations now provide input into 21% of all drug health technology assessments (HTAs) globally and up to 52% in some therapy areas in EU and Commonwealth countries.
Verbatim extraction verified: The figure 21% is directly attested in the quoted passage (Patient organizations now provide input into 21% of all drug health technology assessments (HTAs) globally and up to 52% in some therapy areas in EU and Commonwealth countries.).
The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.
- APA
- IQVIA Institute. (2023). Supporting patients through research collaboration. Retrieved September 16, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/supporting-patients-through-research-collaboration. Via StatOrigin, https://statorigin.org/stat/stat_2PDYD6WDHANXDRA4GCD6QEQ700
- MLA
- IQVIA Institute. "Supporting patients through research collaboration." 2023, https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/supporting-patients-through-research-collaboration. Accessed 16 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_2PDYD6WDHANXDRA4GCD6QEQ700.
- Chicago
- IQVIA Institute. "Supporting patients through research collaboration." 2023. https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/supporting-patients-through-research-collaboration. Accessed September 16, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_2PDYD6WDHANXDRA4GCD6QEQ700.
- BibTeX
- @misc{iqvia2023patientqeq700, author = {{IQVIA Institute}}, title = {Supporting patients through research collaboration}, year = {2023}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_2PDYD6WDHANXDRA4GCD6QEQ700}, note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/supporting-patients-through-research-collaboration. Accessed September 16, 2026.} }
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Chain of Custody · Verification Audit
Primary Source
- Publisher
- IQVIA Institute · homepage ↗
- Authority tier
- Tier 3 · Industry & Research
- Report
- Supporting patients through research collaboration
- Type
- Press release
- Published
- —
- Locator
- Patient organizations now provide input into 21% of all drug health technology assessments (HTAs) globally and up to 52% in some therapy areas in EU and Commonwealth countries.
- Retrieved
- 16 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification & Integrity
- Audit status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Archival URI
- /stat/stat_2PDYD6WDHANXDRA4GCD6QEQ700